Loading provider…
Loading provider…
Hematology & Oncology Physician in Fort Smith, AR
NPI: 1356553101Primary Employer
Durham Veterans Affairs Medical Center
va.gov
HQ Phone
Mobile
Get M.D. Olga's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 18 | 32 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 13 | 25 |
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.
Authors: Murali Janakiram, Gaurav Choudhary, Noah Kornblum, Swati Goel, Lee Ratner, Adam Binder, Ira Braunschweig
Publication Date: 2018-01-01
Authors: David Prezant, Kerry Kelly
Journal: Lancet
Authors: Lizamarie Bachier-Rodriguez, Stephen Peeke, Murali Janakiram, Nishi Shah, Aditi Shastri, Noah Kornblum, Mendel Goldfinger, Joan Uehlinger, Kira Gritsman, Amit Verma, Ira Braunschweig
Journal: J Hematol Oncol
Publication Date: 2020-01-03
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: Canadian Cancer Trials Group
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, PROCEDURE: Biospecimen Collection, DRUG: Dexamethasone, DRUG: Cyclophosphamide, DRUG: Cytarabine, DRUG: Prednisone, DRUG: Etoposide, DRUG: Vincristine Sulfate, BIOLOGICAL: Rituximab, DRUG: Methotrexate, PROCEDURE: X-Ray Imaging, DRUG: Vincristine, PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation, PROCEDURE: Bone Marrow Aspiration, BIOLOGICAL: Blinatumomab, DRUG: Mercaptopurine, DRUG: Daunorubicin, PROCEDURE: Lumbar Puncture, DRUG: Pegaspargase, DRUG: Leucovorin Calcium, DRUG: Daunorubicin Hydrochloride
Lead Sponsor: Chimerix
Intervention / Treatment: DRUG: CMX001